|
81
|
Product specific BE guideline |
Memantine HCl tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
82
|
Product specific BE guideline |
Paliperidone ER Tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
83
|
Product specific BE guideline |
Pregabalin capsule_生體相等性試驗指導原則
|
2020-07-21 |
|
84
|
Product specific BE guideline |
Solifenacin succinate tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
85
|
Product specific BE guideline |
Zolpidem Tartrate ER Tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
86
|
Product specific BE guideline |
Zolpidem Tartrate Tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
87
|
Medical Device |
ICT健康促進產品屬性評估參考建議
|
2020-05-04 |
|
88
|
Pharm/tox |
基因治療製劑非臨床藥毒理研發策略指導原則
|
2020-04-17 |
|
89
|
Clinical |
基因治療製劑臨床研發策略指導原則
|
2020-03-24 |
|
90
|
Clinical |
抗體藥物複合體藥品藥動藥效及臨床研發策略指導原則
|
2019-11-28 |
